Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
about
Meta-analysis of nasopharyngeal carcinoma microarray data explores mechanism of EBV-regulated neoplastic transformationEpstein-Barr virus-specific methylation of human genes in gastric cancer cells.Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumorsAmino acids in the basic domain of Epstein-Barr virus ZEBRA protein play distinct roles in DNA binding, activation of early lytic gene expression, and promotion of viral DNA replication.Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated MalignanciesAn Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Epstein-Barr virus gene expression in human breast cancer: protagonist or passenger?Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileThe Epstein-Barr virus LF2 protein inhibits viral replicationEpstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology.Chlorpyrifos Induces the Expression of the Epstein-Barr Virus Lytic Cycle Activator BZLF-1 via Reactive Oxygen Species.DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic AlterationsNon-integrating lentiviral vectors for specific killing of Epstein-Barr virus nuclear antigen 1-positive B cell lymphoma cells.Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.Epstein-Barr virus LF2 protein regulates viral replication by altering Rta subcellular localization.Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas.Gastric adenocarcinoma microRNA profiles in fixed tissue and in plasma reveal cancer-associated and Epstein-Barr virus-related expression patterns.High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinomaZEB1 and c-Jun levels contribute to the establishment of highly lytic Epstein-Barr virus infection in gastric AGS cells.Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
P2860
Q30844939-BE3833F4-AFE8-44C9-8AE6-31FBDFE0701AQ34504229-D6436347-2523-49FA-A859-BEA34BBA0304Q34767204-84E693D1-6A23-489E-A423-DD8B19883B48Q35024349-A0ACFD7C-68AE-43A8-BA5B-EFE44FFE1041Q35233147-6C588507-9E02-444C-9EE0-F7D8B492648DQ35829978-580852DC-A70F-45AF-97AB-33E3F9834116Q36171933-DC4C2F7B-55F8-4151-9660-98D1B748EAB6Q36670819-A7D32242-1957-42D1-8B09-BB5607DFAE8EQ36687528-381E331D-5647-4237-A814-87540FC4DAEAQ36845933-E5D56207-A89E-4386-8727-920978D4D1FFQ38101668-97E26807-384F-4068-AF95-0D56E0F3F463Q38844955-56DC3BDE-B785-469E-B8DF-E35BFF7F2107Q39455821-89E090D4-2DDD-4A3A-B1BB-184D4E6D5158Q39488698-887D4AA9-4805-416B-89C4-0EAD2369C099Q39515516-B75CBDA3-52F7-4901-A78C-DDC918C9ED0DQ39680157-EA313B6B-D15B-49F4-8611-5C31CDF9FC4EQ40594969-917D9B07-57EC-49CF-B3F8-1C2A4FBDF081Q40764983-BA8173A3-CC77-466E-8163-3624BC65A3F1Q41983423-E699FDF3-62C1-4996-83D5-A8B569B39E54Q42638304-1DC8827F-122C-4739-906B-41BF20E18403Q45360289-8072C7C9-DB38-4B91-A370-87C788840E1E
P2860
Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Use of adenovirus vectors expr ...... to treat EBV-positive tumors.
@ast
Use of adenovirus vectors expr ...... to treat EBV-positive tumors.
@en
Use of adenovirus vectors expressing Epstein-Barr virus
@nl
type
label
Use of adenovirus vectors expr ...... to treat EBV-positive tumors.
@ast
Use of adenovirus vectors expr ...... to treat EBV-positive tumors.
@en
Use of adenovirus vectors expressing Epstein-Barr virus
@nl
prefLabel
Use of adenovirus vectors expr ...... to treat EBV-positive tumors.
@ast
Use of adenovirus vectors expr ...... to treat EBV-positive tumors.
@en
Use of adenovirus vectors expressing Epstein-Barr virus
@nl
P2093
P2860
P921
P1433
P1476
Use of adenovirus vectors expr ...... 1 to treat EBV-positive tumors
@en
P2093
Amy Mauser
Eva Westphal
Margaret L Gulley
Nancy Raab-Traub
Shannon C Kenney
Wen-hai Feng
P2860
P304
10951-10959
P356
10.1128/JVI.76.21.10951-10959.2002
P407
P577
2002-11-01T00:00:00Z